Synairgen

Research Capabilities

NEWS

Synairgen has specialised scientific research and clinical teams dedicated to drug discovery and development in asthma, COPD and other respiratory diseases. Their main activities are summarised opposite:

Research

  • Advanced human in vitro models generated from the BioBank samples, including use of virus infection models (experienced in use of rhinovirus, RSV, influenza etc.)
  • Lung biomarker validation and assessment
  • Application of human tissue models for:
    • Target discovery
    • Target validity
    • Support clinical activity

Clinical

  • Extensive BioBank of relevant tissue, cells, blood and airway secretions from volunteers (both diseased and healthy)
  • Phase I &II trial capability in respiratory patients during naturally acquired cold infections

For more detailed information please go to Technology and Programmes

Investors